SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZMO -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (202)12/12/1999 11:00:00 AM
From: scaram(o)uche  Respond to of 438
 
Mike:

>> and all that was listed as "research stage" <<

Guess I'm still here for the ATIII.

- g -

Thanks!

Rick



To: Mike McFarland who wrote (202)12/12/1999 7:22:00 PM
From: jeffbas  Respond to of 438
 
Thanks Mike. However, I understand that the original human trials were not with the vaccine enhanced with IL2. The mouse results were
significantly better with IL2, based on my non-scientist interpretation.

It seems they are keeping the human results progress in the new trials quiet. Is that standard on non-blinded trials in progress -- nobody gives progress reports? Is there any (negative) implication as to the results?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News